Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.
- DOI
- 10.1007/s40263-026-01315-7
- Published
- 2026-07-28
- Container
- CNS Drugs
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40263-026-01315-7,
title = {Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.},
author = {McIntyre RS and Kato M and Thase ME and Therrien F and Marrache AM and Ikehara K and Ardic F and Boucher M.},
year = {2026},
journal = {CNS Drugs},
doi = {10.1007/s40263-026-01315-7},
url = {https://doi.org/10.1007/s40263-026-01315-7}
}RIS
TY - JOUR TI - Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence. AU - McIntyre RS AU - Kato M AU - Thase ME AU - Therrien F AU - Marrache AM AU - Ikehara K AU - Ardic F AU - Boucher M. PY - 2026 JO - CNS Drugs DO - 10.1007/s40263-026-01315-7 UR - https://doi.org/10.1007/s40263-026-01315-7 ER -
APA
RS, M., M, K., ME, T., F, T., AM, M., K, I., F, A., & M., B. (2026). Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.. CNS Drugs. https://doi.org/10.1007/s40263-026-01315-7
Source records
- europe-pmc · retrieved 2026-09-26T13:10:48.479Z